SFC Fluidics has inked a two-year deal with JDRF to develop an automated insulin delivery system that combines a continuous glucose monitor and an insulin delivery algorithm into a single disposable device.
JDRF is slated to provide funding to the medical device company as part of its Artificial Pancreas Project, which aims to accelerate the development of commercially available closed-loop systems.
Get the full story at our sister site, Drug Delivery Business News.
